SHERIDAN, Stephen William, Friedrich WETTERLING, Jeffrey Moore TESTANI, Barry A A BORLAUG, Marat FUDIM, Kevin DAMMAN, Alastair GRAY, Peter GAINES, Martin POLOCZEK, Stephen MADDEN, Tucker JAMES, Teresa BUXO, Robert GAUL, Louise CORCORAN, Fiachra SWEENEY a Daniel BURKHOFF. Safety and performance of a novel implantable sensor in the inferior vena cava under acute and chronic intravascular volume modulation. European Journal of heart Failure. Hoboken: Wiley, 2023, roč. 25, č. 5, s. 754-763. ISSN 1388-9842. Dostupné z: https://dx.doi.org/10.1002/ejhf.2822.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Safety and performance of a novel implantable sensor in the inferior vena cava under acute and chronic intravascular volume modulation
Autoři SHERIDAN, Stephen William, Friedrich WETTERLING (garant), Jeffrey Moore TESTANI, Barry A A BORLAUG, Marat FUDIM, Kevin DAMMAN, Alastair GRAY, Peter GAINES, Martin POLOCZEK (203 Česká republika, domácí), Stephen MADDEN, Tucker JAMES, Teresa BUXO, Robert GAUL, Louise CORCORAN, Fiachra SWEENEY a Daniel BURKHOFF.
Vydání European Journal of heart Failure, Hoboken, Wiley, 2023, 1388-9842.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 18.200 v roce 2022
Kód RIV RIV/00216224:14110/23:00131029
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1002/ejhf.2822
UT WoS 000946155400001
Klíčová slova anglicky Heart failure; Inferior vena cava; Right atrial pressure; Models; Animal; Chronic and acute response; Intravascular congestion
Štítky 14110211, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 5. 4. 2024 08:29.
Anotace
Aims The management of congestion is one of the key treatment targets in heart failure. Assessing congestion is, however, difficult. The purpose of this study was to investigate the safety and dynamic response of a novel, passive, inferior vena cava (IVC) sensor in a chronic ovine model.Methods and results A total of 20 sheep divided into three groups were studied in acute and chronic in vivo settings. Group I and Group II included 14 sheep in total with 12 sheep receiving the sensor and two sheep receiving a control device (IVC filter). Group III included an additional six animals for studying responses to volume challenges via infusion of blood and saline solutions. Deployment was 100% successful with all devices implanted; performing as expected with no device-related complications and signals were received at all observations. At similar volume states no significant differences in IVC area normalized to absolute area range were measured (55 +/- 17% on day 0 and 62 +/- 12% on day 120, p = 0.51). Chronically, the sensors were completely integrated with a thin, reendothelialized neointima with no loss of sensitivity to infused volume. Normalized IVC area changed significantly from 25 +/- 17% to 43 +/- 11% (p =0.007) with 300 ml infused. In contrast, right atrial pressure required 1200 ml of infused volume prior to a statistically significant change from 3.1 +/- 2.6 mmHg to 7.5 +/- 2.0 mmHg (p = 0.02).Conclusion In conclusion, IVC area can be measured remotely in real-time using a safe, accurate, wireless, and chronic implantable sensor promising to detect congestion with higher sensitivity than filling pressures.
VytisknoutZobrazeno: 17. 5. 2024 02:59